Kopran Ltd.

NSE: KOPRAN BSE: 524280 SECTOR: Pharmaceuticals & Drugs  14k   62   12

250.85
-7.45 (-2.88%)
NSE: Today, 03:52 PM

Price Summary

Today's High

₹ 268.75

Today's Low

₹ 246.4

52 Week High

₹ 272

52 Week Low

₹ 99.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

1084.94 Cr.

Enterprise Value

1097.43 Cr.

No. of Shares

4.33 Cr.

P/E

74.26

P/B

4.43

Face Value

₹ 10

Div. Yield

0.6 %

Book Value (TTM)

₹  56.67

CASH

3.22 Cr.

DEBT

15.72 Cr.

Promoter Holding

43.78 %

EPS (TTM)

₹  3.38

Sales Growth

24.29%

ROE

9.85 %

ROCE

13.57%

Profit Growth

109.2 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year24.29%
3 Year13.18%
5 Year3.53%

Profit Growth

1 Year109.2%
3 Year70.85%
5 Year15.46%

ROE%

1 Year9.85%
3 Year6.99%
5 Year5.53%

ROCE %

1 Year13.57%
3 Year10.07%
5 Year9%

Debt/Equity

0.0637

Price to Cash Flow

22.25

Interest Cover Ratio

9.59148343709775

CFO/PAT (5 Yr. Avg.)

1.43367633578758

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 43.78 0
Jun 2021 43.78 0
Mar 2021 43.78 0
Dec 2020 43.78 0
Sep 2020 43.78 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 30.0004 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 9.59148343709775.
  • Company’s PEG ratio is 0.680051810818341.
  • The company has an efficient Cash Conversion Cycle of 54.5995034813342 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.43367633578758.

 Limitations

  • The company has shown a poor revenue growth of 13.1802836051953% for the Past 3 years.
  • Company has a poor ROE of 6.99157674744712% over the past 3 years.
  • The company is trading at a high EV/EBITDA of 41.1651.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021
Net Sales 47.07 56.56 61.97 29.22 56.23
Total Expenditure 37.67 51.27 54.91 28.7 51.62
Operating Profit 9.41 5.29 7.06 0.52 4.6
Other Income 3.26 2.52 2.23 2.35 1.97
Interest 1.12 0.7 0.54 0.66 0.53
Depreciation 1.05 1.05 1.05 1.08 1.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 10.51 6.07 7.71 1.14 4.96
Tax 3.02 1.74 2.07 0.27 1.18
Profit After Tax 7.49 4.33 5.64 0.87 3.78
Adjusted EPS (Rs) 1.73 1 1.3 0.2 0.87

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 181.54 153.7 196.65 179.29 222.83
Total Expenditure 164.19 146.44 173.95 156.11 192.68
Operating Profit 17.35 7.26 22.7 23.18 30.15
Other Income 9.12 9.56 3.22 1.99 10.46
Interest 9.79 6.63 5.46 5.96 3.81
Depreciation 3.34 3.22 3.11 3.47 4.1
Exceptional Items 0 0 0 0 0
Profit Before Tax 13.35 6.96 17.36 15.73 32.71
Tax 4.85 2.25 4.39 4.51 9.23
Net Profit 8.5 4.71 12.97 11.22 23.47
Adjusted EPS (Rs.) 1.97 1.09 3 2.59 5.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 43.25 43.25 43.25 43.25 43.25
Total Reserves 157.69 162.5 175.19 186.42 203.6
Borrowings 28.06 21.89 21.71 9.67 2.36
Other N/C liabilities -2.34 -0.95 0.65 2.64 6.17
Current liabilities 79.21 69.91 74.81 83.87 68.57
Total Liabilities 305.87 296.61 315.61 325.85 323.95
Assets
Net Block 39.34 38.15 41.88 42.95 47.44
Capital WIP 2.96 5.28 0.94 0.94 0
Intangible WIP 1.48 2.56 5.82 6.13 2.82
Investments 156.6 156.92 157.52 158.14 158.79
Loans & Advances 1.59 1.72 1.93 3.38 3.74
Other N/C Assets 0.01 0.07 0.11 0.08 0.04
Current Assets 103.89 91.91 107.42 114.23 111.12
Total Assets 305.87 296.61 315.61 325.85 323.95
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 13.35 6.96 17.36 15.73 32.71
Adjustment 15.81 6.04 3.32 11.64 7.38
Changes in Assets & Liabilities -24.06 2.52 -4.9 -13.53 14.1
Tax Paid -0.91 -3.02 -3.94 -3.87 -5.41
Operating Cash Flow 4.2 12.5 11.84 9.97 48.77
Investing Cash Flow -8.88 -1.94 -4.47 0.63 -8.51
Financing Cash Flow 4.64 -10.71 -7.43 -10.6 -40.14
Net Cash Flow -0.04 -0.15 -0.06 0 0.12

Corporate Actions

Investors Details

PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Promoters 43.78 43.78 43.78 43.78 43.78
oricon enterprises... 13.91 13.91 13.91 13.91 -
oricon properties ... - - - - 13.78
panorama finvest p... 8.79 8.79 8.79 8.79 8.79
sarvamangal mercan... 6.71 6.71 6.71 6.71 6.71
rajendra somani 5.37 5.37 5.37 5.37 5.37
susheel somani 2.02 2.02 2.02 2.02 2.02
surendra somani 1.16 1.16 1.16 1.16 1.16
parijat shipping a... 0.89 0.89 0.89 0.89 0.89
g.claridge & compa... 0.79 0.79 0.79 0.79 0.79
vandana somani 0.75 0.75 0.75 0.75 0.75
varun somani 0.63 0.63 0.63 0.63 0.63
nupur somani 0.62 0.62 0.62 0.62 0.62
jaya somani 0.60 0.60 0.60 0.60 0.60
mridula somani 0.53 0.53 0.53 0.53 0.53
adarsh somani 0.42 0.42 0.42 0.42 0.42
hridai shusheel so... 0.27 0.27 0.27 0.27 0.27
suhrid somani 0.22 0.22 0.22 0.22 0.22
somani kumkum 0.08 0.08 0.08 0.08 0.08
kopran lifestyle l... 0.01 0.01 0.01 0.01 0.01
PARTICULARS Sep 2020% Dec 2020% Mar 2021% Jun 2021% Sep 2021%
Investors 56.22 56.22 56.22 56.22 56.22
laxminarayan vyapa... - - - 1.48 -
rikeen pradip dalal - - 1.24 - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ2FY21 9 Nov 2020
  • PresentationQ3FY21 20 May 2021
  • PresentationQ4FY21 11 Jun 2021

Kopran Stock Price Analysis and Quick Research Report. Is Kopran an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kopran and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 48.7676 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kopran has a Debt to Equity ratio of 0.0637 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kopran , the EPS growth was 109.197440444068 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kopran has OPM of 13.5322355610544 % which is a bad sign for profitability.
     
  • ROE: Kopran have a poor ROE of 9.85150944793933 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Kopran

X